Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Gorondaz - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Gorondaz

Approved

STANDARD

Gorondaz

Hebei Tiancheng Pharmaceutical Co., Ltd🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: ac58f6436fd8c5b4
Company: Hebei Tiancheng Pharmaceutical Co., Ltd
Type: Standard

Approval Details

Approval Id: ac58f6436fd8c5b4
Drug Approval Philippines Name: Gorondaz
Product Name: Gorondaz
Registration Number: DRP-8458-04
Brand Name: Gorondaz
Generic Name: Metronidazole
Dosage Form: Solution for I.V. Infusion
Dosage Strength: 5 mg / mL (500 mg/100 mL)
Manufacturer: Hebei Tiancheng Pharmaceutical Co., Ltd
Importer: AMB HK Enterprises Inc
Distributor: Applied Pharmaceutical Distribution Inc
Issuance Date: 27 October 2024
Expiry Date: 10 October 2029
Pharmacologic Category: Antiprotozoal (Nitroimidazole Derivative)
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

ac58f6436fd8c5b4

Type

Standard

Back to Philippines FDA Approvals